96 related articles for article (PubMed ID: 20827184)
1. Human natural killer cells: news in the therapy of solid tumors and high-risk leukemias.
Pietra G; Vitale C; Pende D; Bertaina A; Moretta F; Falco M; Vacca P; Montaldo E; Cantoni C; Mingari MC; Moretta A; Locatelli F; Moretta L
Cancer Immunol Immunother; 2016 Apr; 65(4):465-76. PubMed ID: 26289090
[TBL] [Abstract][Full Text] [Related]
2. Donor Age Correlates With Liver-Resident Natural Killer Cell Activity in Adoptive Immunotherapy Using Donor Liver Natural Killer Cells in Liver Transplantation.
Ohira M; Imaoka K; Bekki T; Sato K; Imaoka Y; Nakano R; Yano T; Doskali M; Shimizu S; Chogahara I; Sato S; Nakamura M; Tanaka Y; Ohdan H
Transplant Proc; 2024 Apr; 56(3):667-671. PubMed ID: 38326202
[TBL] [Abstract][Full Text] [Related]
3. Building a Fit for Purpose Clinical Trials Infrastructure to Accelerate the Assessment of Novel Hematopoietic Cell Transplantation Strategies and Cellular Immunotherapies.
Devine SM; Horowitz MM
J Clin Oncol; 2021 Feb; 39(5):534-544. PubMed ID: 33434065
[No Abstract] [Full Text] [Related]
4. The Promise and Peril of Natural Killer Cell Therapies in Pulmonary Infection.
Rajaram S; Canaday LM; Ochayon DE; Rangel KM; Ali A; Gyurova IE; Krishnamurthy D; Fletcher JS; Reighard SD; Cox A; Weirauch MT; Kottyan LC; Deshmukh H; Zacharias WJ; Borchers MT; Waggoner SN
Immunity; 2020 Jun; 52(6):887-889. PubMed ID: 32405233
[No Abstract] [Full Text] [Related]
5. HLA-C KIR-Ligands Determine the Impact of Anti-Thymocyte Globulin (ATG) on Graft versus Host and Graft versus Leukemia Effects Following Hematopoietic Stem Cell Transplantation.
Clausen J; Böhm A; Straßl I; Stiefel O; Buxhofer-Ausch V; Machherndl-Spandl S; König J; Schmidt S; Steitzer H; Danzer M; Kasparu H; Weltermann A; Nachbaur D
Biomedicines; 2017 Mar; 5(2):. PubMed ID: 28536356
[TBL] [Abstract][Full Text] [Related]
6. CD56dimCD57+NKG2C+ NK cell expansion is associated with reduced leukemia relapse after reduced intensity HCT.
Cichocki F; Cooley S; Davis Z; DeFor TE; Schlums H; Zhang B; Brunstein CG; Blazar BR; Wagner J; Diamond DJ; Verneris MR; Bryceson YT; Weisdorf DJ; Miller JS
Leukemia; 2016 Feb; 30(2):456-63. PubMed ID: 26416461
[TBL] [Abstract][Full Text] [Related]
7. Murine NK cell intrinsic cytokine-induced memory-like responses are maintained following homeostatic proliferation.
Keppel MP; Yang L; Cooper MA
J Immunol; 2013 May; 190(9):4754-62. PubMed ID: 23530145
[TBL] [Abstract][Full Text] [Related]
8. KIR2DS2 and KIR2DS4 promoter hypomethylation patterns in patients undergoing hematopoietic cell transplantation (HCT).
Gallez-Hawkins GM; Li X; Franck AE; Gendzekhadze K; Nakamura R; Forman SJ; Senitzer D; Zaia JA
Hum Immunol; 2012 Nov; 73(11):1109-15. PubMed ID: 22939905
[TBL] [Abstract][Full Text] [Related]
9. Phase 1 Clinical Trial of Trametes versicolor in Women with Breast Cancer.
Torkelson CJ; Sweet E; Martzen MR; Sasagawa M; Wenner CA; Gay J; Putiri A; Standish LJ
ISRN Oncol; 2012; 2012():251632. PubMed ID: 22701186
[TBL] [Abstract][Full Text] [Related]
10. Enhanced immunomodulatory activity of gelatin-encapsulated Rubus coreanus Miquel nanoparticles.
Seo YC; Choi WY; Lee CG; Cha SW; Kim YO; Kim JC; Drummen GP; Lee HY
Int J Mol Sci; 2011; 12(12):9031-56. PubMed ID: 22272118
[TBL] [Abstract][Full Text] [Related]
11. Alloreactivity as therapeutic principle in the treatment of hematologic malignancies. Studies of clinical and immunologic aspects of allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning.
Petersen SL
Dan Med Bull; 2007 May; 54(2):112-39. PubMed ID: 17521527
[TBL] [Abstract][Full Text] [Related]
12. Pre-emptive immunotherapy with purified natural killer cells after haploidentical SCT: a prospective phase II study in two centers.
Stern M; Passweg JR; Meyer-Monard S; Esser R; Tonn T; Soerensen J; Paulussen M; Gratwohl A; Klingebiel T; Bader P; Tichelli A; Schwabe D; Koehl U
Bone Marrow Transplant; 2013 Mar; 48(3):433-8. PubMed ID: 22941380
[TBL] [Abstract][Full Text] [Related]
13. Natural killer cell recognition of missing self and haploidentical hematopoietic transplantation.
Ruggeri L; Mancusi A; Burchielli E; Perruccio K; Aversa F; Martelli MF; Velardi A
Semin Cancer Biol; 2006 Oct; 16(5):404-11. PubMed ID: 16916611
[TBL] [Abstract][Full Text] [Related]
14. Natural killer cells and tumor control.
Cooley S; Weisdorf DS
Curr Opin Hematol; 2010 Nov; 17(6):514-21. PubMed ID: 20827184
[TBL] [Abstract][Full Text] [Related]
15. Clinical applications of adoptive natural killer cell immunotherapy for cancer: current status and future prospects.
Guo H; Qian X
Onkologie; 2010; 33(7):389-95. PubMed ID: 20631487
[TBL] [Abstract][Full Text] [Related]
16. Natural killer cell alloreactivity and haplo-identical hematopoietic transplantation.
Ruggeri L; Mancusi A; Burchielli E; Aversa F; Martelli MF; Velardi A
Cytotherapy; 2006; 8(6):554-8. PubMed ID: 17148031
[TBL] [Abstract][Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
